• Target：
• ERK1/2

• Gene Name：
• erk1/2

• Human Gene Id：

• Human Swiss Prot No：
• P27361;P28482

• Immunogen：
• Human p44 MAPK (Erk1) synthetic peptide conjugated to KLH.

• Specificity：
• This antibody detects endogenous levels of p44/42 MAPK (Erk1/2) and does not cross-react with related proteins.

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Monoclonal, Mouse

• Dilution：
• wb dilution 1:1000

• Purification：
• The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• ERK 1;ERK 2;ERK-2;ERK1;erk1/2;ERK2;ERT1;ERT2;Extracellular signal regulated kinase 1;Extracellular signal regulated kinase 1;Extracellular signal regulated kinase 2;Extracellular signal regulated kinase 2;Extracellular signal-regulated kinase 2;HS44KDAP;HUMKER1A;Insulin stimulated MAP2 kinase;MAP kinase 1;MAP kinase 2;MAP kinase isoform p42;MAP kinase isoform p44;MAPK 1;MAPK 2;MAPK 3;MAPK 3;MAPK1;MAPK2;MAPK3;MGC20180;Microtubule associated protein 2 kinase;Mitogen activated protein kinase 1;Mitogen activated protein kinase 1;Mitogen activated protein kinase 2;Mitogen activated protein kinase 3;Mitogen activated protein kinase 3;Mitogen-activated protein kinase 1;Mitogen-activated protein kinase 2;MK01_HUMAN;p38;p40;p41;p41mapk;p42 MAPK;p42-MAPK;p42MAPK;p42MAPK;p44 ERK1;p44 MAPK;p44ERK1;p44ERK1;p44MAPK;p44MAPK;PRKM 1;PRKM 1;PRKM 2;PRKM 2;PRKM 3;PRKM 3;PRKM1;PRKM2;PRKM3;Protein kinase mitogen activated 1;Protein kinase mitogen activated 1;Protein kinase mitogen activated 2;Protein kinase

• Observed Band(KD)：
• 42/44kD

Inhibitory effects of oxymatrine on TGF‑β1‑induced proliferation and abnormal differentiation in rat cardiac fibroblasts via the p38MAPK and ERK1/2 signaling pathways. Molecular Medicine Reports Mol Med Rep. 2017 Oct;16(4):5354-5362 WB Rat 1:1000 cardiac fibroblast (CFB)

The FGF6 amplification mutation plays an important role in the progression and treatment of malignant meningioma Translational Oncology Ruihao Liang WB Human IOMM-LEE cell,CH157MN cell

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs